deltatrials
Terminated PHASE3 INTERVENTIONAL 1-arm NCT03610048

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

A Phase 3b Extension Study of Adjunctive ALKS 5461 in the Treatment of Refractory Major Depressive Disorder

Sponsor: Alkermes, Inc.

Interventions ALKS 5461
Updated 10 times since 2018 Last updated: Jun 29, 2021 Started: Aug 9, 2018 Primary completion: May 1, 2020 Completion: May 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor Decision

A PHASE3 clinical study on Refractory Major Depressive Disorder, this trial is terminated or withdrawn. The trial is conducted by Alkermes, Inc. and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshotNot Yet Recruiting~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshotEnrolling By Invitation~Dec 2018 – ~May 2019 · 5 months · monthly snapshotEnrolling By Invitation~May 2019 – ~Apr 2020 · 11 months · monthly snapshotEnrolling By Invitation~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshotEnrolling By Invitation~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotTerminated~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotTerminated~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Sep 2021 [monthly]

    Terminated PHASE3

  5. Jun 2020 — Jan 2021 [monthly]

    Terminated PHASE3

    Status: Enrolling By InvitationTerminated

Show 5 earlier versions
  1. Apr 2020 — Jun 2020 [monthly]

    Enrolling By Invitation PHASE3

  2. May 2019 — Apr 2020 [monthly]

    Enrolling By Invitation PHASE3

  3. Dec 2018 — May 2019 [monthly]

    Enrolling By Invitation PHASE3

  4. Sep 2018 — Dec 2018 [monthly]

    Enrolling By Invitation PHASE3

    Status: Not Yet RecruitingEnrolling By Invitation

  5. Aug 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alkermes, Inc.
Data source: Alkermes, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .